RedCarpetLife
#0 World Rank
Sergio Stevanato & family

Sergio Stevanato & family

0% | $ 0M
S. family
Rank
#0
Net Worth
$00.0B
Gender
Male
Age
82Y
Country
Italy
Born On
May, 1943
Deceased
No
Relationship Status
Married
Children
2
Education

University Of Bologna - Law Degree

Designation Info :

Self-Made
No
Type
Family Wealth (Inherited And Expanded)
Organization Name
Stevanato Group
Title
Chairman Emeritus
Source

Stevanato Group

Industry
Manufacturing, Healthcare

About S. family


S ergio Stevanato is an Italian billionaire and the chairman emeritus of the Stevanato Group, a global leader in pharmaceutical glass packaging and drug delivery systems. The company has its roots in a small glassworks factory founded by his father, Giovanni Stevanato, in 1949. After joining the family business, Sergio Stevanato demonstrated a keen vision for growth and innovation, transforming the local operation into a multinational corporation that is a critical supplier to the global pharmaceutical industry.

Under his leadership, the Stevanato Group became a premier manufacturer of glass vials, syringes, and cartridges, essential for packaging vaccines and other injectable drugs. He spearheaded the company's international expansion, establishing production plants across Europe, North and South America, and Asia. Recognizing the evolving needs of the pharmaceutical sector, he also diversified the business into high-tech engineering, creating systems for inspecting and assembling drug packaging. In 2021, he led the company through a successful IPO on the New York Stock Exchange, marking a major milestone in its history. The family, including his children Franco and Marco who now hold key executive roles, retains a controlling stake in the company.

Quick Reads


  • Chairman Emeritus of the Stevanato Group, a leading pharma packaging company.
  • The company was founded by his father, Giovanni Stevanato, in 1949.
  • He transformed the family business into a global leader in glass vials and syringes.
  • A critical supplier for COVID-19 vaccine packaging.
  • Led the company to a successful IPO on the New York Stock Exchange in 2021.

More Profiles


Advertisement

You May Like